Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-028207
Filing Date
2024-09-03
Accepted
2024-09-03 07:22:46
Documents
10
Period of Report
2024-09-24

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A wint20240830_def14a.htm DEF 14A 824366
2 graph01.jpg GRAPHIC 35868
3 graph02.jpg GRAPHIC 31545
4 pc01.jpg GRAPHIC 244840
5 pc02.jpg GRAPHIC 190739
6 wt01.jpg GRAPHIC 10275
7 wt02.jpg GRAPHIC 2523
8 wt03.jpg GRAPHIC 2512
9 wt04.jpg GRAPHIC 2822
10 wt05.jpg GRAPHIC 27630
  Complete submission text file 0001437749-24-028207.txt   1582242
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39290 | Film No.: 241271905
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)